• Japanese
  • Korean
  • Chinese
Cover Image

Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2012

Abstract

Summary

GlobalData's clinical trial report, "Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2012" provides data on the Alpha- Antitrypsin Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alpha- Antitrypsin Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Alpha- Antitrypsin Deficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Alpha- Antitrypsin Deficiency Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Alpha- Antitrypsin Deficiency, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Alpha- Antitrypsin Deficiency
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials by Country
    • Top Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Alpha- Antitrypsin Deficiency
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
    • Baxter International Inc.
    • Clinical Trial Overview of Baxter International Inc.
    • Grifols, S.A.
    • Clinical Trial Overview of Grifols, S.A.
    • F. Hoffmann-La Roche Ltd.
    • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
    • Kamada Ltd.
    • Clinical Trial Overview of Kamada Ltd.
    • CSL Limited
    • Clinical Trial Overview of CSL Limited
    • Bayer AG
    • Clinical Trial Overview of Bayer AG
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals
    • Medical University of South Carolina
    • Clinical Trial Overview of Medical University of South Carolina
    • University of Florida
    • Clinical Trial Overview of University of Florida
    • University of Massachusetts
    • Clinical Trial Overview of University of Massachusetts
    • Klinikum Berchtesgadener Land der Schon-Kliniken
    • Clinical Trial Overview of Klinikum Berchtesgadener Land der Schon-Kliniken
    • Hospices Civils de Lyon
    • Clinical Trial Overview of Hospices Civils de Lyon
    • Assistance Publique - Hopitaux de Paris
    • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
    • University of Pittsburgh
    • Clinical Trial Overview of University of Pittsburgh
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Zone, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, BRIC Countries, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, G7 Countries, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, E7 Countries, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Phase, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Terminated Clinical Trials, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Kamada Ltd., 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Klinikum Berchtesgadener Land der Schon-Kliniken, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012*

List of Figures

  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, G7 Countries (%), 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • GlobalData Methodology
Show More
Pricing